Hydrochloric Acid

Hydrochloric Acid

SCHEMBL604178

Cc1cccc(C)c1-[n+]1ccc(-c2cc[n+](CCP(=O)(O)O)cc2)cc1.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ MEN1 O00255 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ GGPS1 O95749 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL604112 0.87 PGK1 (0.33) FDPSKDM4EALDH1A1RAB9A
SCHEMBL5565749 0.86 PGK1 (0.33) FDPSMEN1TP53CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL210855 0.81 MEN1 (0.38) KDM4EALDH1A1RAB9AMEN1TP53
SCHEMBL1226951 0.79 MEN1 (0.39) KDM4EALDH1A1RAB9AMEN1TP53
Hydrochloric Acid SCHEMBL600761 0.78 ALDH1A1 (0.39) FDPSKDM4EALDH1A1RAB9AMEN1
Bromide SCHEMBL918125 0.78 MEN1 (0.38) KDM4EALDH1A1RAB9AMEN1TP53
Hydrochloric Acid SCHEMBL3143919 0.78 CYP2A6 (0.36) KDM4EALDH1A1RAB9AMEN1CYP1A2
Hydrochloric Acid SCHEMBL234296 0.77 PGK1 (0.33) FDPSKDM4EALDH1A1RAB9AMEN1
Hydrochloric Acid SCHEMBL2266110 0.77 ACP3 (0.35) FDPSKDM4EALDH1A1
Hydrochloric Acid SCHEMBL3364505 0.77 MEN1 (0.40) KDM4EALDH1A1RAB9AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8786932-B2 Advanced electrode structures and electrochromic devices NTERA, INC. (US) 2014-07-22 — — US claimed
US-20120038967-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES NTERA LIMITED (IE) 2012-02-16 — — US claimed
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US claimed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US claimed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP claimed
US-8999430-B2 Method of manufacturing display element KONICA MINOLTA HOLDINGS, INC. (JP) 2015-04-07 — — US disclosed
US-8786932-B2 Advanced electrode structures and electrochromic devices NTERA, INC. (US) 2014-07-22 — — US disclosed
EP-2149816-B1 METHOD OF MANUFACTURING AN ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2014-05-07 — — EP disclosed
US-20120038967-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES NTERA LIMITED (IE) 2012-02-16 — — US disclosed
US-8014056-B2 Display element and method of driving the same KONICA MINOLTA HOLDINGS, INC. (JP) 2011-09-06 — — US disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 — — US disclosed
US-20100166946-A1 METHOD OF MANUFACTURING DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2010-07-01 — — US disclosed
US-20090316249-A1 ELECTROCHROMIC DISPLAY DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-12-24 — — US disclosed
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US disclosed
US-7567371-B2 Electrochromic compounds NTERA LIMITED (IE) 2009-07-28 — — US disclosed
EP-2040115-A1 ELECTROCHROMIC DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2009-03-25 — — EP disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP disclosed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED FDPS 3265/4885KDM4E 1692/4885ALDH1A1 1280/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED FDPS 3265/4885KDM4E 1692/4885ALDH1A1 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback